These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3022518)

  • 1. Compensated 131I-therapy of solitary autonomous thyroid nodules: effect on thyroid size and early hypothyroidism.
    Hegedüs L; Veiergang D; Karstrup S; Hansen JM
    Acta Endocrinol (Copenh); 1986 Oct; 113(2):226-32. PubMed ID: 3022518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of solitary autonomous thyroid nodules treated with 131I.
    Goldstein R; Hart IR
    N Engl J Med; 1983 Dec; 309(24):1473-6. PubMed ID: 6646172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effect of radioactive iodine on thyroid function and size in patients with solitary autonomously functioning toxic thyroid nodules.
    Nygaard B; Hegedüs L; Nielsen KG; Ulriksen P; Hansen JM
    Clin Endocrinol (Oxf); 1999 Feb; 50(2):197-202. PubMed ID: 10396362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up in toxic solitary autonomous thyroid nodules treated with radioactive iodine.
    Huysmans DA; Corstens FH; Kloppenborg PW
    J Nucl Med; 1991 Jan; 32(1):27-30. PubMed ID: 1988632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is standard 555 MBq 131I-therapy of hyperthyroidism ablative?
    Bertelsen J; Herskind AM; Sprogøe Jakobsen U; Hegedüs L
    Thyroidology; 1992 Dec; 4(3):103-6. PubMed ID: 1285034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism.
    Ross DS; Ridgway EC; Daniels GH
    Ann Intern Med; 1984 Oct; 101(4):488-90. PubMed ID: 6476634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of longterm outcome of radioiodine therapy of sporadic non-toxic goitre.
    Le Moli R; Wesche MF; Tiel-Van Buul MM; Wiersinga WM
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):783-9. PubMed ID: 10468951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Iodine-131 therapy of autonomous adenoma of the thyroid. 7-year results].
    Heinze HG; Bohn U
    Dtsch Med Wochenschr; 1987 Jul; 112(27):1073-9. PubMed ID: 3595467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
    Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
    J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of thyroid scintigraphies after 131I therapy of solitary autonomous thyroid nodules.
    Nygaard B; Jarløv AE; Hegedüs L; Schaadt B; Kristensen LO; Hansen JM
    Thyroid; 1994; 4(2):167-71. PubMed ID: 7522683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the thyroid technetium-99m scintigram after antithyroid and subsequent radioiodine treatment for solitary autonomous nodules.
    Nygaard B
    Thyroid; 1998 Mar; 8(3):223-7. PubMed ID: 9545108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up studies on iodine-131 treatment of hyperthyroid Graves' disease based on the measurement of thyroid volume by ultrasonography.
    Tsuruta M; Nagayama Y; Yokoyama N; Izumi M; Nagataki S
    Ann Nucl Med; 1993 Aug; 7(3):193-7. PubMed ID: 8217496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of radioactive iodine (I-131) treatment of patients with autonomic adenoma of the thyroid].
    Sowiński J; Gembicki M
    Endokrynol Pol; 1987; 38(4):331-42. PubMed ID: 3454742
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of solitary toxic thyroid nodule with 131I: results in 43 patients].
    Marín JF; Maraña G; Salto L; Astigarraga B; Estrada FJ; Lucas T; Barceló B
    Med Clin (Barc); 1991 May; 96(19):730-2. PubMed ID: 1875750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH
    Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum TSH and the responsiveness of toxic solitary autonomous thyroid nodules to radioiodine therapy.
    Pedersen-Bjergaard U; Kirkegaard C
    Eur J Endocrinol; 1998 Dec; 139(6):587-90. PubMed ID: 9916862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the risk of development of hypothyroidism after iodine 131 treatment with the pretreatment pattern of sodium pertechnetate Tc 99m uptake in the thyroid gland in cats with hyperthyroidism: 165 cases (1990-2002).
    Nykamp SG; Dykes NL; Zarfoss MK; Scarlett JM
    J Am Vet Med Assoc; 2005 May; 226(10):1671-5. PubMed ID: 15906566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in thyroid volume after radioactive iodine therapy in patients with single toxic thyroid nodule].
    Gołkowski F; Jabrocka-Hybel A; Huszno B
    Przegl Lek; 2005; 62(5):284-6. PubMed ID: 16334533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [131I-treatment of the autonomous toxic nodule. Assessment of a fixed dose protocol].
    Abós MD; Banzo J; Razola P; García F; Prats E
    Rev Esp Med Nucl; 1999 Dec; 18(6):431-5. PubMed ID: 10611569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early change of thyroid hormone concentration after 131I treatment in patients with solitary toxic adenoma.
    Pirnat E; Fidler V; Zaletel K; Gaberscek S; Hojker S
    Nuklearmedizin; 2002; 41(4):178-83. PubMed ID: 12224401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.